Company description

Medpace Holdings, Inc. (MEDP) is a global clinical research organization that offers a range of services to biopharmaceutical and medical device companies. The company's clinical development services include conducting laboratory and analytical testing, designing study protocols, recruiting patients, managing clinical trials, and analyzing and reporting results. Medpace operates in over 45 countries and has experience conducting studies in a variety of therapeutic areas, including cardiovascular, oncology, neurology, and infectious diseases. The company's customers include small and mid-sized biotech companies, as well as large pharmaceutical companies. Medpace's competitive advantage lies in its ability to provide specialized and flexible services tailored to meet the specific needs of its clients. The company prides itself on its high-quality data and efficient study start-up process, allowing for faster drug development and time to market for its clients. With a strong financial track record and a highly experienced management team, Medpace is well-positioned for continued growth and success in the highly competitive clinical research industry.